Cash-rich Pfizer snaps up Global Blood Therapeutics for $5.4 billion

·

·

Cash-rich Pfizer snaps up Global Blood Therapeutics for $5.4 billion

The acquisition of the company behind one of the few FDA-approved treatments for sickle cell disease, is the latest blockbuster deal for Pfizer, which has been looking for veins of long-term growth following a cash bonanza driven by its covid-19 vaccine.
See Original Article

Slaughter and May London Associate Joins White & Case As Partner

Yu’s expertise includes advising on public and private M&A transactions, joint ventures, equity raisings and large-scale corporate reorganisations, among other matters, the statement added. Yu is the firm’s eighth London M&A partner …
See Original Article

Carlyle CEO Kewsong Lee steps down in abrupt early departure

Private equity firm Carlyle Group Inc said on Sunday that Chief Executive Kewsong Lee, 56, has stepped down with immediate effect. The announcement comes months before the scheduled end of his five-year contract. The firm, which reported earnings two …
See Original Article

How a four-day workweek could be better for the climate

Reducing the workweek to four days could have a climate benefit, advocates say. In addition to improving the well-being of workers, they say slashing working hours may reduce carbon emissions. It’s …
See Original Article

American Accounting Association

Promoting excellence in accounting education, research, and practice, the American Accounting Association is the largest community of accountants
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.